The importance of genetic contributions to the partial epilepsies is now we
ll established. Evidence for this genetic contribution has come from famili
al aggregation studies, twin studies, positional cloning of specific genes
that raise risk, and clinical descriptions of families. Familial aggregatio
n studies are consistent in showing an increased risk of epilepsy in the re
latives of patients with partial epilepsies that occur in the absence of en
vironmental insults to the central nervous system. Susceptibility genes hav
e been localized in five syndromes: autosomal dominant nocturnal frontal lo
be epilepsy (20q, 1q, and 15q), autosomal dominant partial epilepsy with au
ditory features (10q), familial partial epilepsy with variable foci (22q),
benign epilepsy of childhood with centrotemporal spikes ( 15q), and benign
familial infantile convulsions (19q). In nocturnal frontal lobe epilepsy, t
he genes on chromosome 20q and Iq have been identified as subunits of the n
euronal nicotinic acetylcholine receptor.